BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 18087233)

  • 1. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
    Hughes RA
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis and treatment of CIDP].
    Sobue G
    Rinsho Shinkeigaku; 2005 Nov; 45(11):963-5. PubMed ID: 16447774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with chronic inflammatory demyelinating polyneuropathy.
    Van Doorn PA
    Rev Neurol (Paris); 1996 May; 152(5):383-6. PubMed ID: 8881435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
    Kazmi MA; Mahdi-Rogers M; Sanvito L
    Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Results of a French national opinion survey].
    Azulay JP; Puget S; Goulamhoussen N; Pouget J
    Rev Neurol (Paris); 2008 Dec; 164(12):1035-43. PubMed ID: 18808772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
    Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
    J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Kissel JT
    Semin Neurol; 2003 Jun; 23(2):169-80. PubMed ID: 12894382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of intravenous immunoglobulin in CIDP.
    Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
    Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Guimarães-Costa R; Iancu Ferfoglia R; Viala K; Léger JM
    Rev Neurol (Paris); 2014 Oct; 170(10):595-601. PubMed ID: 25200479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
    Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.